Gene Symbol | Gene ID | Gene Info |
---|---|---|
BATF
|
ENSG00000156127.6 | basic leucine zipper ATF-like transcription factor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr14_75989792_75990178 | BATF | 1082 | 0.528482 | -0.91 | 7.6e-04 | Click! |
chr14_75980780_75980966 | BATF | 7895 | 0.202913 | -0.89 | 1.1e-03 | Click! |
chr14_76009366_76009945 | BATF | 20752 | 0.154557 | -0.88 | 1.7e-03 | Click! |
chr14_76008615_76009046 | BATF | 19927 | 0.156912 | -0.88 | 1.7e-03 | Click! |
chr14_75989621_75989772 | BATF | 793 | 0.650266 | -0.87 | 2.3e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr16_11295567_11296301 | 4.27 |
RMI2 |
RecQ mediated genome instability 2 |
47572 |
0.08 |
chr17_45343433_45343839 | 2.90 |
ENSG00000238419 |
. |
6850 |
0.14 |
chr1_209780440_209781046 | 2.75 |
LAMB3 |
laminin, beta 3 |
11400 |
0.16 |
chr17_48718114_48718630 | 2.52 |
ABCC3 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
6154 |
0.13 |
chr11_65678995_65679525 | 2.51 |
C11orf68 |
chromosome 11 open reading frame 68 |
6571 |
0.08 |
chr14_61651282_61651639 | 2.43 |
PRKCH |
protein kinase C, eta |
2817 |
0.34 |
chr4_23946972_23947800 | 2.43 |
PPARGC1A |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
55686 |
0.17 |
chr1_31870163_31870721 | 2.35 |
SERINC2 |
serine incorporator 2 |
11970 |
0.15 |
chr2_19986384_19986783 | 2.27 |
TTC32 |
tetratricopeptide repeat domain 32 |
114819 |
0.06 |
chr14_77368134_77368285 | 2.23 |
ENSG00000223174 |
. |
11603 |
0.21 |
chr9_16540961_16541659 | 2.21 |
RP11-183I6.2 |
|
68124 |
0.12 |
chr4_74527594_74528063 | 2.21 |
RASSF6 |
Ras association (RalGDS/AF-6) domain family member 6 |
41480 |
0.17 |
chr20_62313922_62314355 | 2.18 |
RTEL1 |
regulator of telomere elongation helicase 1 |
5554 |
0.1 |
chr15_89710472_89711584 | 2.17 |
RLBP1 |
retinaldehyde binding protein 1 |
44046 |
0.12 |
chr12_76577459_76577716 | 2.14 |
ENSG00000252858 |
. |
44240 |
0.17 |
chr16_64899046_64899197 | 2.12 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
194460 |
0.03 |
chr21_36077513_36077851 | 2.12 |
CLIC6 |
chloride intracellular channel 6 |
35994 |
0.17 |
chr9_91144416_91144843 | 2.11 |
NXNL2 |
nucleoredoxin-like 2 |
5387 |
0.32 |
chr8_23654560_23654711 | 2.11 |
ENSG00000207027 |
. |
9255 |
0.19 |
chr1_9750618_9751880 | 2.10 |
RP11-558F24.4 |
|
3636 |
0.21 |
chr9_72837523_72837792 | 2.09 |
ENSG00000222465 |
. |
33991 |
0.14 |
chr5_52105602_52106304 | 2.06 |
CTD-2288O8.1 |
|
22093 |
0.18 |
chr11_67141426_67142374 | 2.05 |
CLCF1 |
cardiotrophin-like cytokine factor 1 |
252 |
0.81 |
chr11_67124730_67125439 | 2.05 |
POLD4 |
polymerase (DNA-directed), delta 4, accessory subunit |
4067 |
0.1 |
chr2_208049155_208049306 | 2.03 |
KLF7 |
Kruppel-like factor 7 (ubiquitous) |
17239 |
0.2 |
chr5_80263425_80263779 | 2.00 |
CTC-459I6.1 |
|
6876 |
0.24 |
chr1_246023169_246023412 | 2.00 |
RP11-83A16.1 |
|
173563 |
0.03 |
chr17_76296960_76297664 | 1.97 |
SOCS3 |
suppressor of cytokine signaling 3 |
58843 |
0.08 |
chr2_172619845_172620139 | 1.97 |
AC068039.4 |
|
10000 |
0.22 |
chr1_214731522_214731884 | 1.97 |
PTPN14 |
protein tyrosine phosphatase, non-receptor type 14 |
7137 |
0.28 |
chr7_98717947_98718887 | 1.97 |
SMURF1 |
SMAD specific E3 ubiquitin protein ligase 1 |
23225 |
0.2 |
chr4_8192745_8193409 | 1.97 |
SH3TC1 |
SH3 domain and tetratricopeptide repeats 1 |
8014 |
0.22 |
chr2_28497749_28498516 | 1.96 |
AC093690.1 |
|
35194 |
0.19 |
chr17_63188018_63188169 | 1.95 |
RGS9 |
regulator of G-protein signaling 9 |
54501 |
0.15 |
chr18_21207750_21207901 | 1.95 |
ANKRD29 |
ankyrin repeat domain 29 |
21661 |
0.17 |
chr6_41680801_41681561 | 1.95 |
RP11-298J23.5 |
|
6953 |
0.13 |
chr8_21766211_21767399 | 1.93 |
DOK2 |
docking protein 2, 56kDa |
4369 |
0.22 |
chr2_69058944_69060252 | 1.93 |
AC097495.2 |
|
422 |
0.85 |
chr4_120130830_120131163 | 1.89 |
RP11-455G16.1 |
Uncharacterized protein |
2671 |
0.26 |
chr11_46312622_46312792 | 1.89 |
CREB3L1 |
cAMP responsive element binding protein 3-like 1 |
3970 |
0.21 |
chr3_13394182_13394652 | 1.89 |
NUP210 |
nucleoporin 210kDa |
67392 |
0.12 |
chr2_9252566_9252858 | 1.87 |
ASAP2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
94182 |
0.08 |
chr11_118782916_118784128 | 1.87 |
BCL9L |
B-cell CLL/lymphoma 9-like |
1909 |
0.16 |
chr7_98047722_98048054 | 1.84 |
BAIAP2L1 |
BAI1-associated protein 2-like 1 |
17508 |
0.24 |
chr15_89202319_89202812 | 1.83 |
ISG20 |
interferon stimulated exonuclease gene 20kDa |
20381 |
0.16 |
chr11_118490692_118490843 | 1.82 |
PHLDB1 |
pleckstrin homology-like domain, family B, member 1 |
12409 |
0.11 |
chr20_61372315_61372887 | 1.81 |
RP11-93B14.4 |
|
5902 |
0.14 |
chr16_57843731_57844652 | 1.80 |
CTD-2600O9.1 |
uncharacterized protein LOC388282 |
358 |
0.83 |
chr13_101527725_101527876 | 1.80 |
NALCN-AS1 |
NALCN antisense RNA 1 |
167221 |
0.04 |
chr9_35518799_35519162 | 1.79 |
RUSC2 |
RUN and SH3 domain containing 2 |
19649 |
0.14 |
chr8_107467845_107467996 | 1.78 |
OXR1 |
oxidation resistance 1 |
7768 |
0.33 |
chr1_999104_999751 | 1.78 |
RP11-465B22.3 |
|
968 |
0.35 |
chr3_45677341_45677693 | 1.77 |
LIMD1 |
LIM domains containing 1 |
41166 |
0.12 |
chr17_17319727_17320387 | 1.77 |
ENSG00000201741 |
. |
43701 |
0.12 |
chr10_82232631_82233415 | 1.77 |
TSPAN14 |
tetraspanin 14 |
13965 |
0.2 |
chr2_225715115_225715266 | 1.76 |
DOCK10 |
dedicator of cytokinesis 10 |
33821 |
0.24 |
chr7_105410894_105411045 | 1.76 |
ATXN7L1 |
ataxin 7-like 1 |
78885 |
0.11 |
chr18_10015316_10015467 | 1.75 |
ENSG00000263630 |
. |
10197 |
0.26 |
chr6_10633412_10633876 | 1.75 |
GCNT6 |
glucosaminyl (N-acetyl) transferase 6 |
349 |
0.86 |
chr10_633862_634058 | 1.74 |
DIP2C |
DIP2 disco-interacting protein 2 homolog C (Drosophila) |
4060 |
0.23 |
chr14_23316976_23317711 | 1.74 |
ENSG00000212335 |
. |
4594 |
0.09 |
chr9_21507220_21507371 | 1.74 |
ENSG00000199177 |
. |
4889 |
0.17 |
chr1_109372086_109372237 | 1.73 |
AKNAD1 |
AKNA domain containing 1 |
23178 |
0.15 |
chr18_9704973_9705544 | 1.73 |
RAB31 |
RAB31, member RAS oncogene family |
2904 |
0.31 |
chr1_23065095_23065396 | 1.73 |
ENSG00000216157 |
. |
10159 |
0.16 |
chr6_44002412_44002760 | 1.72 |
ENSG00000265518 |
. |
21848 |
0.15 |
chr8_123770654_123770805 | 1.71 |
ZHX2 |
zinc fingers and homeoboxes 2 |
22904 |
0.2 |
chr1_225697588_225697739 | 1.70 |
RP11-496N12.6 |
|
44618 |
0.15 |
chr7_128469504_128470247 | 1.70 |
FLNC |
filamin C, gamma |
556 |
0.68 |
chr17_55967739_55968110 | 1.70 |
CUEDC1 |
CUE domain containing 1 |
2125 |
0.29 |
chr20_10020938_10021230 | 1.69 |
SNAP25-AS1 |
SNAP25 antisense RNA 1 |
5112 |
0.21 |
chr22_30604075_30604921 | 1.67 |
RP3-438O4.4 |
|
1400 |
0.33 |
chr6_82648031_82648424 | 1.67 |
ENSG00000206886 |
. |
174486 |
0.03 |
chr3_125230252_125231290 | 1.67 |
ENSG00000201800 |
. |
5052 |
0.18 |
chr15_34415216_34415367 | 1.67 |
PGBD4 |
piggyBac transposable element derived 4 |
21017 |
0.15 |
chr2_122118297_122118448 | 1.66 |
CLASP1 |
cytoplasmic linker associated protein 1 |
66674 |
0.12 |
chr5_148606762_148607149 | 1.66 |
ABLIM3 |
actin binding LIM protein family, member 3 |
15956 |
0.16 |
chr5_98396799_98396950 | 1.66 |
ENSG00000200351 |
. |
124423 |
0.06 |
chr3_29228707_29228858 | 1.66 |
RBMS3 |
RNA binding motif, single stranded interacting protein 3 |
93691 |
0.09 |
chr1_183845727_183845989 | 1.65 |
COLGALT2 |
collagen beta(1-O)galactosyltransferase 2 |
69894 |
0.11 |
chr7_1196429_1196848 | 1.65 |
ZFAND2A |
zinc finger, AN1-type domain 2A |
730 |
0.57 |
chr12_93018090_93018241 | 1.65 |
C12orf74 |
chromosome 12 open reading frame 74 |
78454 |
0.09 |
chr2_161276442_161277443 | 1.64 |
RBMS1 |
RNA binding motif, single stranded interacting protein 1 |
4253 |
0.24 |
chr19_35809860_35810427 | 1.64 |
CD22 |
CD22 molecule |
21 |
0.95 |
chr3_98498207_98498752 | 1.64 |
ST3GAL6 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 6 |
8580 |
0.2 |
chr11_111604143_111604294 | 1.64 |
PPP2R1B |
protein phosphatase 2, regulatory subunit A, beta |
21544 |
0.16 |
chr9_110266716_110266867 | 1.64 |
KLF4 |
Kruppel-like factor 4 (gut) |
14028 |
0.22 |
chr1_241755534_241755712 | 1.64 |
KMO |
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
23688 |
0.17 |
chr8_103802696_103803356 | 1.63 |
ENSG00000266799 |
. |
57079 |
0.11 |
chr9_84174156_84174449 | 1.63 |
TLE1 |
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) |
54135 |
0.17 |
chr19_18887031_18887461 | 1.63 |
COMP |
cartilage oligomeric matrix protein |
14868 |
0.14 |
chr1_202428794_202428945 | 1.63 |
PPP1R12B |
protein phosphatase 1, regulatory subunit 12B |
3002 |
0.28 |
chr6_82724453_82724882 | 1.63 |
ENSG00000223044 |
. |
195490 |
0.03 |
chr5_156943664_156943815 | 1.63 |
ADAM19 |
ADAM metallopeptidase domain 19 |
13909 |
0.17 |
chr22_39649533_39650209 | 1.62 |
AL031590.1 |
|
7192 |
0.14 |
chr14_69015594_69016105 | 1.62 |
CTD-2325P2.4 |
|
79313 |
0.1 |
chr2_238410967_238411392 | 1.62 |
MLPH |
melanophilin |
15260 |
0.18 |
chr2_192031923_192032186 | 1.61 |
STAT4 |
signal transducer and activator of transcription 4 |
15732 |
0.22 |
chr2_101508416_101508699 | 1.61 |
NPAS2 |
neuronal PAS domain protein 2 |
33051 |
0.18 |
chr7_6056109_6056260 | 1.61 |
ENSG00000207217 |
. |
324 |
0.77 |
chrY_28466290_28466441 | 1.61 |
ENSG00000252948 |
. |
40771 |
0.2 |
chr9_136858320_136859229 | 1.60 |
VAV2 |
vav 2 guanine nucleotide exchange factor |
1048 |
0.54 |
chr5_14268406_14268609 | 1.60 |
TRIO |
trio Rho guanine nucleotide exchange factor |
22579 |
0.28 |
chr8_123444906_123445057 | 1.60 |
ENSG00000238901 |
. |
238549 |
0.02 |
chr14_92939950_92940432 | 1.60 |
SLC24A4 |
solute carrier family 24 (sodium/potassium/calcium exchanger), member 4 |
34483 |
0.19 |
chr9_112895920_112896071 | 1.60 |
AKAP2 |
A kinase (PRKA) anchor protein 2 |
8214 |
0.28 |
chr1_155223556_155224415 | 1.59 |
FAM189B |
family with sequence similarity 189, member B |
714 |
0.38 |
chr1_26610395_26611734 | 1.58 |
SH3BGRL3 |
SH3 domain binding glutamic acid-rich protein like 3 |
4451 |
0.13 |
chr1_232551545_232551696 | 1.57 |
SIPA1L2 |
signal-induced proliferation-associated 1 like 2 |
46543 |
0.2 |
chr1_167744512_167744663 | 1.57 |
MPZL1 |
myelin protein zero-like 1 |
9780 |
0.23 |
chr1_146763875_146764157 | 1.57 |
CHD1L |
chromodomain helicase DNA binding protein 1-like |
49660 |
0.14 |
chr15_90577870_90579058 | 1.57 |
ENSG00000265871 |
. |
28477 |
0.12 |
chr6_138173620_138173771 | 1.57 |
RP11-356I2.4 |
|
5490 |
0.24 |
chr6_88518297_88518448 | 1.57 |
ENSG00000207131 |
. |
17631 |
0.18 |
chr1_39568795_39569258 | 1.56 |
MACF1 |
microtubule-actin crosslinking factor 1 |
2057 |
0.3 |
chr3_141248480_141249204 | 1.55 |
RASA2-IT1 |
RASA2 intronic transcript 1 (non-protein coding) |
4867 |
0.27 |
chr2_164631908_164632059 | 1.55 |
FIGN |
fidgetin |
39461 |
0.23 |
chr17_1089511_1089756 | 1.55 |
ABR |
active BCR-related |
983 |
0.55 |
chr3_112981272_112981423 | 1.55 |
BOC |
BOC cell adhesion associated, oncogene regulated |
22060 |
0.2 |
chr1_97025248_97025543 | 1.55 |
ENSG00000241992 |
. |
23370 |
0.27 |
chr17_48128276_48128773 | 1.55 |
ITGA3 |
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) |
4815 |
0.16 |
chr1_16277969_16279055 | 1.55 |
ZBTB17 |
zinc finger and BTB domain containing 17 |
7589 |
0.15 |
chr9_127068533_127068868 | 1.54 |
NEK6 |
NIMA-related kinase 6 |
6436 |
0.2 |
chr3_8979023_8979174 | 1.54 |
ENSG00000199815 |
. |
5919 |
0.23 |
chr12_1153501_1153652 | 1.54 |
ERC1 |
ELKS/RAB6-interacting/CAST family member 1 |
16638 |
0.19 |
chr20_30398171_30398354 | 1.53 |
MYLK2 |
myosin light chain kinase 2 |
8849 |
0.15 |
chr16_24787512_24787663 | 1.53 |
TNRC6A |
trinucleotide repeat containing 6A |
15221 |
0.23 |
chr19_39853366_39853517 | 1.53 |
SAMD4B |
sterile alpha motif domain containing 4B |
5985 |
0.09 |
chr11_107416035_107416186 | 1.53 |
ALKBH8 |
alkB, alkylation repair homolog 8 (E. coli) |
20134 |
0.19 |
chr18_396123_396274 | 1.53 |
RP11-720L2.2 |
|
28218 |
0.2 |
chr14_74163250_74163401 | 1.53 |
RP4-693M11.3 |
|
3729 |
0.15 |
chr6_82724884_82725084 | 1.52 |
ENSG00000223044 |
. |
195173 |
0.03 |
chr3_197244192_197244451 | 1.52 |
BDH1 |
3-hydroxybutyrate dehydrogenase, type 1 |
3055 |
0.34 |
chr6_45622533_45622945 | 1.52 |
ENSG00000252738 |
. |
8898 |
0.32 |
chr12_8043408_8043946 | 1.52 |
SLC2A14 |
solute carrier family 2 (facilitated glucose transporter), member 14 |
67 |
0.95 |
chr15_41085579_41085808 | 1.51 |
ZFYVE19 |
zinc finger, FYVE domain containing 19 |
13591 |
0.09 |
chr10_82009607_82010081 | 1.51 |
AL359195.1 |
Uncharacterized protein; cDNA FLJ46261 fis, clone TESTI4025062 |
378 |
0.87 |
chr1_178095572_178095723 | 1.51 |
RASAL2 |
RAS protein activator like 2 |
32371 |
0.24 |
chr4_1331225_1331376 | 1.51 |
UVSSA |
UV-stimulated scaffold protein A |
9754 |
0.13 |
chr1_210611785_210612142 | 1.51 |
HHAT |
hedgehog acyltransferase |
964 |
0.69 |
chr17_13488087_13488238 | 1.51 |
HS3ST3A1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 |
17082 |
0.23 |
chr10_633622_633794 | 1.51 |
DIP2C |
DIP2 disco-interacting protein 2 homolog C (Drosophila) |
3808 |
0.24 |
chr3_98848222_98848373 | 1.51 |
ENSG00000207331 |
. |
220994 |
0.02 |
chr14_53404188_53404339 | 1.51 |
FERMT2 |
fermitin family member 2 |
9125 |
0.26 |
chr11_66103534_66104527 | 1.50 |
RIN1 |
Ras and Rab interactor 1 |
30 |
0.92 |
chr21_37304756_37305187 | 1.50 |
FKSG68 |
|
34244 |
0.16 |
chr16_54482153_54482558 | 1.50 |
ENSG00000264079 |
. |
100953 |
0.08 |
chr2_238162134_238162403 | 1.50 |
AC112715.2 |
Uncharacterized protein |
3466 |
0.34 |
chr6_170098102_170098459 | 1.50 |
ENSG00000265654 |
. |
936 |
0.42 |
chr20_60931885_60932386 | 1.50 |
RP11-157P1.5 |
|
4066 |
0.14 |
chr14_89466929_89467242 | 1.50 |
TTC8 |
tetratricopeptide repeat domain 8 |
159213 |
0.04 |
chr12_13025678_13025838 | 1.49 |
GPRC5A |
G protein-coupled receptor, family C, group 5, member A |
17958 |
0.14 |
chr5_14399490_14399641 | 1.49 |
TRIO |
trio Rho guanine nucleotide exchange factor |
88992 |
0.1 |
chr9_91331342_91331626 | 1.49 |
ENSG00000265873 |
. |
29336 |
0.25 |
chr12_11733022_11733284 | 1.48 |
ENSG00000251747 |
. |
33740 |
0.16 |
chr14_51837951_51838102 | 1.48 |
ENSG00000201820 |
. |
117285 |
0.05 |
chr20_4554675_4555120 | 1.48 |
PRNP |
prion protein |
111985 |
0.06 |
chr19_46979334_46979485 | 1.48 |
PNMAL1 |
paraneoplastic Ma antigen family-like 1 |
4589 |
0.15 |
chr17_27917005_27917997 | 1.48 |
ANKRD13B |
ankyrin repeat domain 13B |
714 |
0.33 |
chr13_32799197_32799490 | 1.48 |
FRY |
furry homolog (Drosophila) |
39462 |
0.17 |
chr6_2976856_2977146 | 1.48 |
SERPINB6 |
serpin peptidase inhibitor, clade B (ovalbumin), member 6 |
4911 |
0.16 |
chr15_74688962_74689487 | 1.47 |
CYP11A1 |
cytochrome P450, family 11, subfamily A, polypeptide 1 |
29143 |
0.11 |
chr15_63180836_63181194 | 1.47 |
RP11-1069G10.1 |
|
4782 |
0.27 |
chr8_72899968_72900383 | 1.47 |
TRPA1 |
transient receptor potential cation channel, subfamily A, member 1 |
77618 |
0.11 |
chr8_131248547_131249235 | 1.46 |
ASAP1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 |
10397 |
0.28 |
chr2_32936280_32936567 | 1.46 |
TTC27 |
tetratricopeptide repeat domain 27 |
32478 |
0.21 |
chr1_214680404_214680555 | 1.46 |
PTPN14 |
protein tyrosine phosphatase, non-receptor type 14 |
42333 |
0.19 |
chr21_43050861_43051153 | 1.46 |
ENSG00000252771 |
. |
26164 |
0.2 |
chr10_99356089_99356377 | 1.46 |
HOGA1 |
4-hydroxy-2-oxoglutarate aldolase 1 |
3326 |
0.16 |
chr6_54156646_54156797 | 1.45 |
TINAG |
tubulointerstitial nephritis antigen |
16043 |
0.27 |
chr9_14271441_14271727 | 1.45 |
NFIB |
nuclear factor I/B |
36428 |
0.2 |
chr1_235242449_235242943 | 1.45 |
ENSG00000207181 |
. |
48556 |
0.13 |
chr13_106796240_106796391 | 1.45 |
ENSG00000222682 |
. |
11524 |
0.25 |
chr2_28325368_28325773 | 1.44 |
ENSG00000265321 |
. |
106336 |
0.06 |
chr2_173861482_173861763 | 1.44 |
RAPGEF4 |
Rap guanine nucleotide exchange factor (GEF) 4 |
29732 |
0.21 |
chr1_227539158_227539309 | 1.44 |
CDC42BPA |
CDC42 binding protein kinase alpha (DMPK-like) |
33058 |
0.22 |
chr16_72405306_72405606 | 1.44 |
ENSG00000207514 |
. |
5147 |
0.31 |
chr19_6109054_6110118 | 1.44 |
CTB-66B24.1 |
|
253 |
0.82 |
chr1_152022964_152023546 | 1.44 |
S100A11 |
S100 calcium binding protein A11 |
13744 |
0.14 |
chr19_39888603_39889701 | 1.44 |
MED29 |
mediator complex subunit 29 |
7100 |
0.08 |
chr3_188296487_188296899 | 1.44 |
LPP-AS1 |
LPP antisense RNA 1 |
10239 |
0.22 |
chr15_62745838_62745989 | 1.43 |
TLN2 |
talin 2 |
107651 |
0.07 |
chr17_48766733_48767153 | 1.43 |
RP11-294J22.6 |
|
3866 |
0.14 |
chr4_22515546_22516022 | 1.43 |
GPR125 |
G protein-coupled receptor 125 |
1836 |
0.52 |
chr1_17559878_17560367 | 1.43 |
PADI1 |
peptidyl arginine deiminase, type I |
272 |
0.9 |
chr11_65343918_65345038 | 1.43 |
EHBP1L1 |
EH domain binding protein 1-like 1 |
961 |
0.3 |
chr14_61725901_61726197 | 1.42 |
ENSG00000252380 |
. |
3701 |
0.23 |
chr15_52386582_52387272 | 1.42 |
CTD-2184D3.5 |
|
5793 |
0.16 |
chr4_17032259_17032410 | 1.42 |
LDB2 |
LIM domain binding 2 |
131902 |
0.06 |
chr2_128327004_128327155 | 1.42 |
MYO7B |
myosin VIIB |
9813 |
0.17 |
chr7_47641377_47641730 | 1.42 |
TNS3 |
tensin 3 |
19397 |
0.24 |
chr7_137652180_137652679 | 1.42 |
AC022173.2 |
|
14335 |
0.2 |
chr2_28019558_28020090 | 1.41 |
AC110084.1 |
|
10638 |
0.17 |
chr1_178096185_178096417 | 1.41 |
RASAL2 |
RAS protein activator like 2 |
33025 |
0.24 |
chr11_76235616_76235767 | 1.41 |
C11orf30 |
chromosome 11 open reading frame 30 |
1815 |
0.42 |
chr18_43381728_43382214 | 1.41 |
SIGLEC15 |
sialic acid binding Ig-like lectin 15 |
23506 |
0.18 |
chr15_38117070_38117334 | 1.41 |
TMCO5A |
transmembrane and coiled-coil domains 5A |
96938 |
0.09 |
chr8_25771009_25771433 | 1.40 |
EBF2 |
early B-cell factor 2 |
25789 |
0.27 |
chr11_69069495_69070094 | 1.40 |
MYEOV |
myeloma overexpressed |
8169 |
0.29 |
chr4_148698718_148698869 | 1.40 |
ENSG00000264274 |
. |
4953 |
0.21 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.7 | GO:0071694 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
2.1 | 8.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.2 | 4.9 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
1.1 | 4.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
1.1 | 6.4 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
1.0 | 3.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.0 | 4.0 | GO:0071731 | response to nitric oxide(GO:0071731) |
1.0 | 3.9 | GO:0070141 | response to UV-A(GO:0070141) |
1.0 | 2.9 | GO:0044415 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.9 | 2.8 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.9 | 2.7 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.9 | 2.6 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.8 | 5.9 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.8 | 2.5 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.8 | 0.8 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.8 | 2.3 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.8 | 4.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.8 | 2.3 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.7 | 3.0 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.7 | 3.7 | GO:0061525 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.7 | 0.7 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.7 | 5.3 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.6 | 1.8 | GO:0002551 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.6 | 1.2 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.6 | 2.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.6 | 1.2 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.6 | 1.7 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.6 | 2.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.6 | 1.7 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.6 | 1.1 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.5 | 2.7 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.5 | 2.2 | GO:0061043 | vascular wound healing(GO:0061042) regulation of vascular wound healing(GO:0061043) |
0.5 | 0.5 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.5 | 1.1 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.5 | 5.7 | GO:0048844 | artery morphogenesis(GO:0048844) artery development(GO:0060840) |
0.5 | 2.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.5 | 5.2 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.5 | 0.5 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.5 | 4.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.5 | 0.5 | GO:0051014 | actin filament severing(GO:0051014) |
0.5 | 1.5 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.5 | 1.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.5 | 9.0 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.5 | 1.5 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.5 | 0.5 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.5 | 1.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.5 | 1.9 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.5 | 1.9 | GO:0009414 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.5 | 1.9 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.5 | 1.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.5 | 3.7 | GO:0006108 | malate metabolic process(GO:0006108) |
0.5 | 1.9 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.5 | 1.8 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.5 | 2.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.5 | 0.9 | GO:0019511 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.5 | 0.9 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.5 | 1.8 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.5 | 1.4 | GO:0034653 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.4 | 1.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.4 | 7.0 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.4 | 1.3 | GO:0022605 | oogenesis stage(GO:0022605) |
0.4 | 1.3 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.4 | 1.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 1.7 | GO:0018101 | protein citrullination(GO:0018101) |
0.4 | 0.8 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.4 | 2.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.4 | 3.4 | GO:0009629 | response to gravity(GO:0009629) |
0.4 | 1.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.4 | 0.4 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.4 | 1.6 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.4 | 0.8 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.4 | 1.6 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.4 | 0.4 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.4 | 1.2 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.4 | 1.2 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.4 | 3.1 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.4 | 2.7 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.4 | 0.4 | GO:0042504 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.4 | 1.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 0.4 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.4 | 0.7 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.4 | 0.4 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.4 | 1.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.4 | 1.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.4 | 1.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.4 | 1.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.4 | 0.7 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.4 | 0.4 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.4 | 0.4 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.3 | 0.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.3 | 0.7 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.3 | 0.3 | GO:0060347 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.3 | 0.7 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.3 | 0.7 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.3 | 1.0 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.3 | 7.8 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.3 | 1.4 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.3 | 0.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 0.3 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.3 | 1.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.3 | 3.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.3 | 0.7 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.3 | 1.3 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.3 | 0.3 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.3 | 3.6 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.3 | 1.0 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.3 | 0.6 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.3 | 2.5 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.3 | 0.3 | GO:0072193 | positive regulation of smooth muscle cell differentiation(GO:0051152) ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.3 | 1.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 0.3 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.3 | 1.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 1.8 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.3 | 0.6 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.3 | 1.2 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.3 | 0.6 | GO:0060413 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.3 | 1.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.3 | 0.3 | GO:0070527 | platelet aggregation(GO:0070527) |
0.3 | 2.0 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.3 | 0.9 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.3 | 1.7 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.3 | 0.8 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.3 | 0.6 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.3 | 0.3 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.3 | 0.8 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.3 | 2.8 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.3 | 1.4 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.3 | 0.3 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) regulation of steroid hormone biosynthetic process(GO:0090030) |
0.3 | 0.8 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.3 | 0.8 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.3 | 1.1 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.3 | 1.4 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.3 | 0.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.3 | 1.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.3 | 0.8 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.3 | 0.8 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.3 | 0.3 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) |
0.3 | 1.0 | GO:0070091 | glucagon secretion(GO:0070091) |
0.3 | 0.5 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.3 | 1.0 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
0.3 | 0.8 | GO:0090189 | regulation of mesonephros development(GO:0061217) regulation of branching involved in ureteric bud morphogenesis(GO:0090189) |
0.3 | 0.5 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.3 | 0.5 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.3 | 1.3 | GO:0010269 | response to selenium ion(GO:0010269) |
0.3 | 0.5 | GO:0050955 | thermoception(GO:0050955) |
0.3 | 0.5 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.2 | 1.0 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.2 | 0.5 | GO:0051280 | negative regulation of ion transmembrane transporter activity(GO:0032413) negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.2 | 1.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 1.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 1.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.2 | 1.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 1.0 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 1.7 | GO:0031269 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 1.2 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.2 | 1.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.2 | 2.4 | GO:0001759 | organ induction(GO:0001759) |
0.2 | 0.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.2 | 0.2 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.2 | 0.9 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.7 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.2 | 2.6 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.2 | 0.2 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.2 | 1.6 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 0.7 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 1.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.2 | 0.7 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.2 | 1.3 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 0.2 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.2 | 0.7 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.4 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.2 | 0.2 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.2 | 0.7 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.2 | 0.2 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.2 | 1.5 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 1.9 | GO:0021988 | olfactory bulb development(GO:0021772) olfactory lobe development(GO:0021988) |
0.2 | 0.2 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.2 | 1.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.2 | 1.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.2 | 1.9 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.2 | 3.4 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.2 | 0.6 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.2 | 0.8 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.2 | 0.4 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.2 | 0.4 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 0.4 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.2 | 1.0 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.2 | 0.6 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 0.8 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.2 | 1.0 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.2 | 0.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 0.6 | GO:0015793 | glycerol transport(GO:0015793) |
0.2 | 1.0 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.2 | 2.4 | GO:0035329 | hippo signaling(GO:0035329) |
0.2 | 1.2 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 0.2 | GO:0034201 | response to oleic acid(GO:0034201) |
0.2 | 1.0 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.2 | 0.4 | GO:0001878 | response to yeast(GO:0001878) |
0.2 | 0.6 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.2 | 0.4 | GO:0045844 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.2 | 0.6 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.2 | 2.5 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.2 | 1.1 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.2 | 0.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 0.2 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.2 | 0.2 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.2 | 0.2 | GO:0060510 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
0.2 | 1.7 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.2 | 0.2 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.2 | 0.7 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
0.2 | 1.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 0.5 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.2 | 0.9 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.2 | 0.4 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.2 | 0.7 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.2 | 0.5 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.2 | 0.9 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.2 | 0.4 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.2 | 0.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 0.9 | GO:0045661 | regulation of myoblast differentiation(GO:0045661) |
0.2 | 0.2 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.2 | 0.5 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 0.9 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.2 | 0.2 | GO:1903392 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.2 | 2.4 | GO:0048286 | lung alveolus development(GO:0048286) |
0.2 | 0.5 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.2 | 0.7 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.2 | 1.0 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.2 | 0.7 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.2 | 0.3 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.2 | 0.5 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 0.5 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.2 | 0.3 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.2 | 7.5 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.2 | 0.7 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.2 | 0.3 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.2 | 0.5 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.2 | 0.3 | GO:0030185 | nitric oxide transport(GO:0030185) |
0.2 | 0.5 | GO:0007494 | midgut development(GO:0007494) |
0.2 | 0.6 | GO:0090399 | replicative senescence(GO:0090399) |
0.2 | 0.6 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.2 | 0.5 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 0.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 0.3 | GO:0060206 | estrous cycle phase(GO:0060206) |
0.2 | 1.3 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.2 | 0.2 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.2 | 0.5 | GO:1903053 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 0.2 | GO:0014848 | urinary tract smooth muscle contraction(GO:0014848) |
0.2 | 2.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 0.5 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 1.4 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.2 | 0.2 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) |
0.2 | 0.3 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 0.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.5 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.2 | 0.8 | GO:0090505 | wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.2 | 0.5 | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.2 | 0.2 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.2 | 0.2 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.2 | 1.1 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.2 | 3.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.2 | 1.4 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.2 | 0.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 1.8 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.2 | 1.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.6 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 1.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.4 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.1 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.3 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.1 | GO:0060119 | inner ear receptor cell development(GO:0060119) inner ear receptor stereocilium organization(GO:0060122) |
0.1 | 0.7 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.1 | 1.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.4 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 1.0 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.7 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.1 | GO:0060491 | regulation of cell projection assembly(GO:0060491) |
0.1 | 0.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 1.0 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.7 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.6 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.4 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 0.4 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.4 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.4 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.8 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.4 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.1 | 0.4 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.4 | GO:0050922 | negative regulation of chemotaxis(GO:0050922) |
0.1 | 0.3 | GO:0060033 | Mullerian duct regression(GO:0001880) anatomical structure regression(GO:0060033) |
0.1 | 0.1 | GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.1 | 1.2 | GO:0030539 | male genitalia development(GO:0030539) |
0.1 | 0.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.4 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.1 | 0.4 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 2.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.4 | GO:2000300 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.3 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.1 | 0.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 1.3 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.6 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.9 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.1 | 0.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.4 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.1 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.2 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 0.4 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.4 | GO:0071027 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 4.8 | GO:0030198 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.1 | 0.4 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 1.4 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.5 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.9 | GO:0021983 | pituitary gland development(GO:0021983) |
0.1 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 1.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 1.8 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.9 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.1 | 0.1 | GO:0042659 | endodermal cell fate commitment(GO:0001711) endodermal cell fate specification(GO:0001714) regulation of gastrulation(GO:0010470) endodermal cell differentiation(GO:0035987) regulation of cell fate specification(GO:0042659) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.1 | 0.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.3 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.9 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.1 | 0.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.2 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) negative regulation of epinephrine secretion(GO:0032811) |
0.1 | 0.3 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.1 | 0.2 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.4 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.1 | 0.5 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.3 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.2 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.2 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.1 | 0.6 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.1 | 0.4 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.1 | GO:0032353 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.1 | 0.5 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.1 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.1 | 0.5 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.1 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.2 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.6 | GO:0008207 | C21-steroid hormone metabolic process(GO:0008207) |
0.1 | 0.3 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.4 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 0.1 | GO:0045683 | negative regulation of epidermis development(GO:0045683) |
0.1 | 0.6 | GO:1901532 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.1 | 0.4 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.3 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 0.1 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.1 | 1.2 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.1 | 0.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.1 | GO:0060996 | dendritic spine development(GO:0060996) |
0.1 | 0.3 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.3 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.1 | 0.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.3 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.3 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.1 | 0.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.4 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.1 | 0.5 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.2 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.1 | 0.3 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.6 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.1 | 1.8 | GO:1901880 | negative regulation of protein depolymerization(GO:1901880) |
0.1 | 0.3 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.6 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.1 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 0.4 | GO:0045329 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.1 | 0.7 | GO:0003229 | ventricular cardiac muscle tissue development(GO:0003229) |
0.1 | 0.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.1 | 0.6 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.4 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.1 | 0.2 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
0.1 | 0.3 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.6 | GO:0045446 | endothelial cell differentiation(GO:0045446) |
0.1 | 0.1 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.1 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.4 | GO:0009750 | response to fructose(GO:0009750) |
0.1 | 0.1 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 0.1 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.1 | 0.2 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 0.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.2 | GO:1901798 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.1 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.3 | GO:0090280 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) positive regulation of calcium ion import(GO:0090280) |
0.1 | 0.5 | GO:1902603 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.1 | 0.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.8 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.2 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 0.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.3 | GO:0048679 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.1 | 0.2 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 0.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.1 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.9 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 0.1 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.2 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.1 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.1 | 0.3 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.5 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.1 | 0.3 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.1 | 0.2 | GO:0043090 | amino acid import(GO:0043090) |
0.1 | 0.5 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.1 | 0.6 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.1 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.1 | 0.2 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.3 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.1 | 0.4 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.2 | GO:0031102 | neuron projection regeneration(GO:0031102) |
0.1 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 0.1 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
0.1 | 0.1 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.5 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.9 | GO:0016358 | dendrite development(GO:0016358) |
0.1 | 0.3 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.5 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.2 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.1 | 0.1 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.1 | 0.3 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.5 | GO:0006586 | tryptophan metabolic process(GO:0006568) tryptophan catabolic process(GO:0006569) indolalkylamine metabolic process(GO:0006586) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.1 | 0.5 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.1 | 0.1 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.5 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 1.0 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.1 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.1 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.1 | 0.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.1 | 0.1 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 0.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.3 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 0.1 | GO:0061365 | positive regulation of lipoprotein lipase activity(GO:0051006) positive regulation of triglyceride lipase activity(GO:0061365) |
0.1 | 0.2 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.1 | 0.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 0.3 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.2 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.1 | 0.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 1.1 | GO:0017156 | calcium ion regulated exocytosis(GO:0017156) |
0.1 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.1 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 0.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.0 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.1 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.0 | 0.2 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.0 | 0.6 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.0 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.0 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 0.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.2 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.0 | 0.2 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.0 | 0.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.2 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.3 | GO:0033280 | response to vitamin D(GO:0033280) |
0.0 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.2 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.0 | 0.2 | GO:0009071 | glycine catabolic process(GO:0006546) serine family amino acid catabolic process(GO:0009071) |
0.0 | 0.3 | GO:0048821 | erythrocyte development(GO:0048821) myeloid cell development(GO:0061515) |
0.0 | 0.1 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.0 | 0.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.0 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.3 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.0 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.4 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.1 | GO:0051963 | regulation of synapse assembly(GO:0051963) |
0.0 | 0.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.0 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.0 | 0.1 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.0 | 0.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.6 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.1 | GO:0034698 | response to gonadotropin(GO:0034698) |
0.0 | 0.2 | GO:0000239 | pachytene(GO:0000239) |
0.0 | 0.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.0 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.0 | 0.1 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.2 | GO:2000144 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.1 | GO:0021930 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.0 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.4 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 0.1 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
0.0 | 0.1 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.0 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.5 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.0 | 0.0 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.1 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.0 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.4 | GO:0044003 | modification by symbiont of host morphology or physiology(GO:0044003) |
0.0 | 0.1 | GO:0030431 | sleep(GO:0030431) |
0.0 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.0 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.0 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.1 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.0 | 0.2 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.0 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.2 | GO:0007143 | female meiotic division(GO:0007143) |
0.0 | 0.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.1 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 0.2 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.0 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.3 | GO:0051789 | obsolete response to protein(GO:0051789) |
0.0 | 0.0 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.0 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.0 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.1 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.0 | 0.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.1 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.1 | GO:0043084 | penile erection(GO:0043084) |
0.0 | 0.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.0 | 0.1 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.0 | 1.0 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 0.0 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 | 0.0 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) positive regulation of cardiocyte differentiation(GO:1905209) |
0.0 | 0.2 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.5 | GO:0034332 | adherens junction organization(GO:0034332) |
0.0 | 0.1 | GO:0019430 | removal of superoxide radicals(GO:0019430) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.0 | 0.2 | GO:0042461 | photoreceptor cell development(GO:0042461) eye photoreceptor cell development(GO:0042462) |
0.0 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.1 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 1.0 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.0 | 0.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.1 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.0 | 0.1 | GO:0009251 | glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.1 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.0 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.1 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.0 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.0 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.0 | 0.4 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.0 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.0 | 0.3 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.0 | 0.1 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.0 | 0.2 | GO:0090132 | epithelial cell migration(GO:0010631) epithelium migration(GO:0090132) |
0.0 | 0.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.0 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.5 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.0 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.1 | GO:0006385 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.0 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.0 | 0.8 | GO:0008544 | epidermis development(GO:0008544) |
0.0 | 0.3 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.0 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.1 | GO:0033059 | cellular pigmentation(GO:0033059) |
0.0 | 0.2 | GO:0046847 | filopodium assembly(GO:0046847) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 6.7 | GO:0030056 | hemidesmosome(GO:0030056) |
1.3 | 4.0 | GO:0030934 | anchoring collagen complex(GO:0030934) |
1.1 | 1.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.0 | 2.9 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.9 | 3.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.8 | 0.8 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.8 | 2.3 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.7 | 4.8 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.6 | 4.4 | GO:0016342 | catenin complex(GO:0016342) |
0.6 | 4.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.5 | 2.7 | GO:0071437 | invadopodium(GO:0071437) |
0.5 | 4.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.5 | 1.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.5 | 1.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.5 | 3.8 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) complex of collagen trimers(GO:0098644) |
0.5 | 1.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.4 | 1.7 | GO:0033268 | node of Ranvier(GO:0033268) |
0.4 | 3.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.4 | 1.9 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.4 | 1.9 | GO:0042599 | lamellar body(GO:0042599) |
0.4 | 1.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 10.0 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.3 | 1.4 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.3 | 2.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.3 | 1.9 | GO:0001527 | microfibril(GO:0001527) |
0.3 | 0.9 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.3 | 1.2 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.3 | 1.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 1.2 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 0.9 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 1.8 | GO:0002102 | podosome(GO:0002102) |
0.3 | 0.6 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.3 | 1.7 | GO:0031512 | motile primary cilium(GO:0031512) |
0.3 | 3.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 4.8 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 7.9 | GO:0030018 | Z disc(GO:0030018) |
0.2 | 1.6 | GO:0043256 | laminin complex(GO:0043256) |
0.2 | 1.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 4.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.2 | 11.3 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 0.7 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 0.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 0.6 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 1.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 8.9 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 1.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 7.6 | GO:0044309 | neuron spine(GO:0044309) |
0.2 | 1.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.2 | 38.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.2 | 1.1 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.2 | 0.6 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 0.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 0.4 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 0.5 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.2 | 18.3 | GO:0005912 | adherens junction(GO:0005912) |
0.2 | 1.2 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 1.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 1.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 0.8 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.2 | 0.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 0.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 0.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 9.2 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.1 | 0.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.3 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.9 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.5 | GO:0001520 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.1 | 6.4 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 1.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 5.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 2.3 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.1 | 2.8 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.3 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.3 | GO:0044217 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 8.8 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 3.7 | GO:0030017 | sarcomere(GO:0030017) |
0.1 | 1.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.6 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.6 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.3 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.1 | 1.6 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 3.7 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 0.7 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.7 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.1 | 0.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.3 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 4.0 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 1.0 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.1 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.5 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.3 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 0.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.3 | GO:0031211 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 1.0 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 4.2 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 0.2 | GO:0045277 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
0.1 | 0.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.2 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.6 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.4 | GO:0090568 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.3 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 4.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.5 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.1 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.0 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 1.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 2.2 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.5 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 1.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.3 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.3 | 3.9 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.2 | 3.7 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
1.2 | 7.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.2 | 4.7 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
1.0 | 2.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.0 | 1.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.9 | 3.7 | GO:0042805 | actinin binding(GO:0042805) |
0.9 | 2.8 | GO:0045545 | syndecan binding(GO:0045545) |
0.9 | 3.6 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.8 | 6.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.8 | 2.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.8 | 2.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.7 | 2.8 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.7 | 7.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.7 | 2.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.6 | 1.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.6 | 1.8 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.6 | 2.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.6 | 1.8 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.6 | 3.4 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.6 | 6.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.5 | 2.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.5 | 2.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.5 | 2.6 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.5 | 1.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.5 | 3.4 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.5 | 1.4 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.5 | 1.9 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.5 | 3.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.5 | 1.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.5 | 1.9 | GO:0048495 | Roundabout binding(GO:0048495) |
0.5 | 2.8 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.5 | 2.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.4 | 1.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.4 | 9.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.4 | 1.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 1.3 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.4 | 1.3 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.4 | 1.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 15.6 | GO:0005518 | collagen binding(GO:0005518) |
0.4 | 4.1 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.4 | 1.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.4 | 7.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.4 | 1.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 0.7 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.4 | 2.6 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.4 | 1.5 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.4 | 1.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.4 | 1.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.4 | 0.7 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.4 | 1.1 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.4 | 1.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 1.0 | GO:0048185 | activin binding(GO:0048185) |
0.3 | 1.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.3 | 1.0 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.3 | 1.0 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.3 | 3.3 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.3 | 2.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 2.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 2.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 1.3 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.3 | 0.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 1.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.3 | 1.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 1.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 1.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 0.9 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.3 | 1.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.3 | 1.2 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 6.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 1.7 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.3 | 4.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 1.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.3 | 0.8 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.3 | 0.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.3 | 1.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.3 | 0.8 | GO:0003896 | DNA primase activity(GO:0003896) |
0.3 | 2.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 2.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.3 | 0.8 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 3.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 2.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 1.0 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 1.0 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 1.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 14.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 0.9 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 0.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 2.6 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.2 | 1.4 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.2 | 0.9 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.2 | 0.7 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 0.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 2.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 0.7 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.2 | 0.9 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 1.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.4 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.2 | 1.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.2 | 0.2 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.2 | 1.7 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.2 | 1.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 0.8 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 0.6 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 2.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 1.6 | GO:0030371 | translation repressor activity(GO:0030371) |
0.2 | 0.8 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 0.4 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 0.6 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 2.3 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.2 | 0.6 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.2 | 1.3 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.2 | 1.2 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 0.6 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.2 | 0.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 0.4 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.2 | 0.6 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 0.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 0.6 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 1.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.2 | 0.9 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 0.7 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 0.4 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.2 | 0.9 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 2.9 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.2 | 1.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 1.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 0.9 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 1.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 1.0 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.2 | 0.3 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.2 | 0.9 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 1.0 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 0.9 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 0.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.5 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.2 | 2.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 0.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 0.5 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.2 | 0.7 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 1.0 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.2 | 1.1 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 1.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 2.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 0.6 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
0.2 | 0.6 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 0.9 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 0.8 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 1.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.7 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 2.1 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.1 | 1.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 1.1 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.4 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.1 | 0.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.3 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 1.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.4 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.5 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 6.1 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) transmembrane receptor protein kinase activity(GO:0019199) |
0.1 | 0.5 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.1 | 0.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 1.2 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 1.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.7 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.6 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.3 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 0.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 3.0 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 1.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 1.5 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.6 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.2 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 0.5 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 2.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 1.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.4 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.1 | 0.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.9 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 10.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.7 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.2 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 1.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 2.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.5 | GO:0005372 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.1 | 0.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.2 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.5 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 2.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.3 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.4 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.1 | 0.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 4.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.1 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.3 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 1.2 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 1.1 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.2 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.1 | 0.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.4 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.2 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 1.1 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.7 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.2 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.9 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.4 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 1.2 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.1 | 4.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.4 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.2 | GO:0032558 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.1 | 0.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.2 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.2 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.8 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 4.3 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 0.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.8 | GO:0019838 | growth factor binding(GO:0019838) |
0.1 | 0.3 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.1 | 0.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 2.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.0 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.0 | 0.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.6 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.3 | GO:0001077 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.0 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.0 | 0.3 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
0.0 | 0.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.5 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.2 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.0 | 1.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.3 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.0 | 0.5 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.0 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 1.1 | GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen(GO:0016705) |
0.0 | 0.3 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 0.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.2 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.3 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.0 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 0.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.1 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.1 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.1 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.2 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 2.0 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 1.5 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 0.3 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.7 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.1 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.1 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.0 | 0.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.1 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.0 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.0 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 0.8 | ST ADRENERGIC | Adrenergic Pathway |
0.7 | 7.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.6 | 0.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 0.5 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.5 | 20.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.4 | 6.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 6.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 7.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 0.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 9.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 0.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 9.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 0.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 1.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 0.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 7.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 33.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 1.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 1.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 2.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 1.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 10.7 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.2 | 0.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 1.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 7.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 3.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 2.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 3.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 4.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 3.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 3.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 2.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 3.6 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 2.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 2.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 19.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 2.5 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 0.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 1.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.0 | PID INSULIN PATHWAY | Insulin Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 9.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.8 | 1.6 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.5 | 6.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 24.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.4 | 9.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 1.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.4 | 4.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.4 | 1.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.3 | 6.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 3.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 3.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 6.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 1.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 7.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 0.5 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.2 | 0.7 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.2 | 0.2 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.2 | 3.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 3.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 2.9 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.2 | 0.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 3.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 4.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 2.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 3.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 4.1 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.2 | 1.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 2.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.2 | 1.3 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 2.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 1.9 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.2 | 0.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.2 | 0.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 1.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 4.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 1.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 0.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 1.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 8.0 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 1.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 3.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 1.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.8 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 1.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 1.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 1.4 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 0.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 5.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 1.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 0.2 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 1.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.7 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 1.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.9 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 1.5 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.9 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.1 | 0.5 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 0.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 0.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.1 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.1 | 0.5 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 0.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 4.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 2.1 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 2.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 2.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.2 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.0 | 0.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |